Volume: 21 Issue: 1

1. High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17. Page:99—106
2. Effects of high glucose with or without other metabolic substrates on alpha-adrenergic contractions in rat mesenteric and femoral arteries. Page:91—97
3. Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice. Page:83—90
4. Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells. Page:75—82
5. Participation of central GABAA receptors in the trigeminal processing of mechanical allodynia in rats. Page:65—74
6. Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models. Page:55—64
7. Metabolism and excretion of novel pulmonary-targeting docetaxel liposome in rabbits. Page:45—54
8. Regulation of vascular smooth muscle phenotype by cross-regulation of krüppel-like factors. Page:37—44
9. Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviors via the activation of GABA(A)-ergic systems in rodents. Page:27—36
10. Betulin suppressed interleukin-1β-induced gene expression, secretion and proteolytic activity of matrix metalloproteinase in cultured articular chondrocytes and production of matrix metalloproteinase in the knee joint of rat. Page:19—26
11. Association study between OCTN1 functional haplotypes and Crohn's disease in a Korean population. Page:11—17
12. Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats. Page:1—9
13. Corrigendum to: Gintonin facilitates catecholamine secretion from the perfused adrenal medulla. Page:141—141
14. Calcium permeability of transient receptor potential canonical (TRPC) 4 channels measured by TRPC4-GCaMP6s. Page:133—140
15. Neuroprotective effect of lithium after pilocarpine-induced status epilepticus in mice. Page:125—131
16. Inhibition of ERK1/2 by silymarin in mouse mesangial cells. Page:117—124
17. Prediction of pharmacokinetics and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach: A case study of caffeine and ciprofloxacin. Page:107—115